v3.26.1
Asset Purchase Agreement (Details) - USD ($)
6 Months Ended
Dec. 10, 2025
Sep. 12, 2025
Jun. 30, 2026
Asset Purchase Agreement [Line Items]      
Annual net sales percentage     2.00%
Haisco Licensing Agreement [Member]      
Asset Purchase Agreement [Line Items]      
Annual net sales percentage     50.00%
Asset Purchase Agreement [Member]      
Asset Purchase Agreement [Line Items]      
Consideration purchase of assets   $ 50,000  
Consideration asset $ 15,000,000   $ 50,000
Direct transaction costs     151,216
Asset Purchase Agreement [Member] | eXIthera Pharmaceuticals, Inc. [Member]      
Asset Purchase Agreement [Line Items]      
Consideration asset   $ 15,000,000  
Veralox APA [Member]      
Asset Purchase Agreement [Line Items]      
Consideration purchase of assets $ 200,000   300,000
Consideration asset     $ 331,797
Annual net sales percentage     5.00%
Direct transaction costs     $ 131,797
Royalty revenue received     200,000,000
Minimum [Member]      
Asset Purchase Agreement [Line Items]      
Royalty expense     10,000
Maximum [Member]      
Asset Purchase Agreement [Line Items]      
Royalty expense     50,000
Veralox Therapeutics Inc. [Member] | Veralox APA [Member]      
Asset Purchase Agreement [Line Items]      
Consideration asset     $ 200,000
Royalty [Member] | Veralox APA [Member]      
Asset Purchase Agreement [Line Items]      
Annual net sales percentage     3.00%
License agreement amount     $ 200,000,000